FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Buyback Record Date | February 23, 2024 |
Buyback Open Date | February 29, 2024 |
Buyback Closing Date | March 6, 2024 |
Issue Size (Shares) | 0.60 Crores |
Issue Size (Amount) | ₹600.00 Crores |
Buyback Price | ₹1005 per Share |
June 28, 2024 3:30:00 AM
Zydus Lifesciences Ltd share price was up by 1.60% from the previous closing price of ?1,057.00. Who are peers of Zydus Lifesciences Ltd? The peers of Zydus Lifesciences Ltd are Sun ...
Published by : Business TodayJune 14, 2024 5:11:00 AM
Zydus Lifesciences has received tentative approval from the United States Food and Drug Administration (USFDA) to market Azilsartan Medoxomil and Chlorthalidone tablets, 40 mg/12.5 mg and 40 mg/25 mg.
Published by : Business LineJune 28, 2024 3:30:00 AM
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Published by : Wall Street JournalJune 10, 2024 11:21:00 AM
In accordance with the Market Abuse Regulation, the details of each transaction made under the share buyback programme are enclosed.
Published by : NasdaqJune 14, 2024 11:40:00 PM
Zydus Lifesciences Ltd on Friday said it has received tentative approval from the US health regulator to market Azilsartan Medoxomil and Chlorthalidone tablets, which are indicated for the ...
Published by : moneycontrol.comJune 3, 2024 2:11:00 PM
Shares of Edwards Lifesciences Corp. got a boost premarket Monday, after the medical-technologies company announced an agreement to sell its critical-care product group to Becton Dickinson & Co ...
Published by : MarketWatchApril 10, 2024 1:43:00 AM
Zydus Lifesciences Ltd on Wednesday said it has received final approval from the US health regulator to market its generic Theophylline extended-release tablets used in the treatment of asthma and ...
Published by : health.economictimes.indiatimesJune 28, 2024 1:29:00 PM
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Published by : MorningstarMay 13, 2024 3:30:00 AM
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Published by : MorningstarRead Zydus Lifesciences Buyback 2024 current news. Find Zydus Lifesciences Buyback 2024 subscription news, Buyback analysis, broker reviews, allotment news, and listing date. Get the Zydus Lifesciences Limited Buyback grey market premium and Zydus Lifesciences Buyback 2024 expected listing price.
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|